US Patent No. 8,889,644

GNAQ-targeted dsRNA compositions and methods for inhibiting expression
Nov 21, 2014

Alnylam Pharmaceuticals has been awarded US Patent No. 8,889,644, "GNAQ-targeted dsRNA compositions and methods for inhibiting expression."

Jared Gollob, Greg Hinkle, Ivanka Toudjarska, and David Bumcrot are named as the inventors.

Thermo Fisher Scientific says it will no longer sell machines in China's Xinjiang region, according to the Wall Street Journal.

New Scientist reports that 20 percent of human and yeast proteins are uncharacterized.

The University of Zurich's Ruedi Aebersold and his colleagues analyzed a dozen HeLa cell lines to find differences in gene expression, protein levels, and more.

In Nature this week: protein-coding variants associated with body-fat distribution, and more.

Sponsored by
Loop Genomics

This webinar provides a comparison of next-generation sequencing (NGS) approaches for human transcriptome sequencing, including short-read Illumina sequencing and synthetic long-read sequencing technology.